Natural product drug discovery and development: the United States National Cancer Institute role

Cragg, Gordon M

Cragg, Gordon M.

Cragg, Gordon M; Frederick Center Research and Development Center. National Cancer Institute. Division of Cancer Treatment and Diagnosis. Developmental Therapeutics Program. Natural Products Branch.

P. R. health sci. j ; 21(2): 97-111, Jun. 2002.

Article in English | LILACS | ID: lil-334438

Subject(s)

Animals; History, 20th Century; Humans; Antineoplastic Agents/isolation & purification; Biological Factors; National Institutes of Health (U.S.); Anti-HIV Agents; Antineoplastic Agents/history; Antineoplastic Agents/therapeutic use; Drug Evaluation/economics; Drug Evaluation/methods; Drug Evaluation, Preclinical/economics; Drug Evaluation, Preclinical/methods; Cooperative Behavior; Drug Design; Biological Factors/history; Biological Factors/isolation & purification; International Cooperation; National Institutes of Health (U.S.); Neoplasms; Plants, Medicinal; United States

Search on Google

XML

Index: LILACS (Americas) Main subject: Biological Factors / National Institutes of Health (U.S.) / Antineoplastic Agents Type of study: Prognostic study Limits: Animals / Humans Country/Region as subject: North America Language: English Journal: P. R. health sci. j Journal subject: Medicine Year: 2002 Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML